Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
William Bensinger
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Chemicals & Drugs
Concepts & Ideas
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
85
Appelbaum, Frederick
78
Buckner, Dean
59
Storb, Rainer
56
Clift, Reginald
36
Rowley, Scott
30
Lilleby, Kathy
27
Holmberg, Leona
27
Demirer, Taner
26
Doney, Kristine
25
Anasetti, Claudio
24
Chauncey, Thomas
17
Deeg, Joachim
17
Maloney, David
16
Sanders, Jean
15
Sanders, Jean
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of William Bensinger (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Rotta Marcello; Storer Barry E; Sahebi Firoozeh; Shizuru Judith A; Bruno Benedetto; Lange Thoralf; Agura Edward D; McSweeney Peter A; Pulsipher Michael A; Hari Parameswaran; Maziarz Richard T; Chauncey Thomas R; Appelbaum Frederick R; Sorror Mohamed L; Bensinger William; Sandmaier Brenda M; Storb Rainer F; Maloney David G
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
-
2009: Bensinger W I
Role of autologous and allogeneic stem cell transplantation in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(3):442-8.
-
2009: Bensinger W; DiPersio J F; McCarty J M
Improving stem cell mobilization strategies: future directions.
Bone marrow transplantation 2009;43(3):181-95.
-
2008: Zaucha Renata; Gooley Ted; Holmberg Leona; Gopal Ajay K; Press Oliver; Maloney David; Bensinger William I
High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.
Leukemia & lymphoma 2008;49(10):1899-906.
-
2008: Gopal Ajay K; Metcalfe Tracee L; Gooley Ted A; Pagel John M; Petersdorf Stephen H; Bensinger William I; Holmberg Leona; Maloney David G; Press Oliver W
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
Cancer 2008;113(6):1344-50.
-
2008: Till Brian G; Gooley Theodore A; Crawford Nathan; Gopal Ajay K; Maloney David G; Petersdorf Stephen H; Pagel John M; Holmberg Leona; Bensinger William; Press Oliver W
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
Leukemia & lymphoma 2008;49(6):1062-73.
-
2008: Bensinger William
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):480-92.
-
2007: Bensinger William I
Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?
Best practice & research. Clinical haematology 2007;20(4):783-95.
-
2007: Pham R N; Gooley T A; Keeney G E; Press O W; Pagel J M; Greisman H A; Bensinger W I; Holmberg L A; Petersdorf S H; Maloney D G; Gopal A K
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.
Bone marrow transplantation 2007;40(11):1039-44.
-
2007: Keeney Grant E; Gooley Ted A; Pham Rosalyn N; Press Oliver W; Pagel John M; Petersdorf Stephen H; Maloney David G; Bensinger William; Holmberg Leona; Gopal Ajay K
The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
Leukemia & lymphoma 2007;48(10):1961-7.
-
2007: Elting Linda S; Shih Ya-Chen Tina; Stiff Patrick J; Bensinger William; Cantor Scott B; Cooksley Catherine; Spielberger Ricardo; Emmanoulides Christos
Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(7):806-13.
-
2007: Bensinger William
Initial Therapy of Multiple Myeloma in Patients who are Candidates for Stem Cell Transplantation.
Current treatment options in oncology 2007;8(2):135-43.
-
2007: Bensinger William I
Reduced intensity allogeneic stem cell transplantation in multiple myeloma.
Frontiers in bioscience : a journal and virtual library 2007;12():4384-92.
-
2006: Stiff Patrick J; Emmanouilides Christos; Bensinger William I; Gentile Teresa; Blazar Bruce; Shea Thomas C; Lu John; Isitt John; Cesano Alessandra; Spielberger Ricardo
Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5186-93.
-
2006: Bensinger W;
Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration.
Bone marrow transplantation 2006;38(8):539-46.
-
2006: Bensinger W I
The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(10):1683-9.
-
2006: Holmberg Leona A; Maloney David; Bensinger William
Immunotherapy with rituximab/interleukin-2 after autologous stem cell transplantation as treatment for CD20+ non-Hodgkin's lymphoma.
Clinical lymphoma & myeloma 2006;7(2):135-9.
-
2006: Lilleby K; Garcia P; Gooley T; McDonnnell P; Taber R; Holmberg L; Maloney D G; Press O W; Bensinger W
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2006;37(11):1031-5.
-
2006: Holmberg Leona; Kikuchi Kaoru; Gooley Ted A; Adams Kristina M; Hockenbery David M; Flowers Mary E D; Schoch H Gary; Bensinger William; McDonald George B
Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):226-34.
-
2006: Stiff P J; Erder H; Bensinger W I; Emmanouilides C; Gentile T; Isitt J; Lu Z J; Spielberger R
Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT).
Bone marrow transplantation 2006;37(4):393-401.
-
2006: Zaucha Renata E; Buckner Dean C; Barnett Todd; Holmberg Leona A; Gooley Ted; Hooper Heather A; Maloney David G; Appelbaum Frederick; Bensinger William I
Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.
International journal of radiation oncology, biology, physics 2006;64(1):227-34.
-
2005: Oehler Vivian G; Radich Jerald P; Storer Barry; Blume Karl G; Chauncey Thomas; Clift Reginald; Snyder David S; Forman Stephen J; Flowers Mary E D; Martin Paul; Guthrie Katherine A; Negrin Robert S; Appelbaum Frederick R; Bensinger William
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):85-92.
-
2005: Sui Xingwei; Bensinger William; Press Oliver
Improved conditioning regimens for autologous transplantation using targeted radiotherapy.
Acta haematologica 2005;114(4):230-8.
-
2004: Spielberger Ricardo; Stiff Patrick; Bensinger William; Gentile Teresa; Weisdorf Daniel; Kewalramani Tarun; Shea Thomas; Yanovich Saul; Hansen Keith; Noga Stephen; McCarty John; LeMaistre C Frederick; Sung Eric C; Blazar Bruce R; Elhardt Dieter; Chen Mon-Gy; Emmanouilides Christos
Palifermin for oral mucositis after intensive therapy for hematologic cancers.
The New England journal of medicine 2004;351(25):2590-8.
-
2004: Adams Kristina M; Holmberg Leona A; Leisenring Wendy; Fefer Alexander; Guthrie Katherine A; Tylee Tracy S; McDonald George B; Bensinger William I; Nelson J Lee
Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation.
Blood 2004;104(6):1894-7.
-
2004: Bensinger William I
The role of hematopoietic stem cell transplantation in the treatment of multiple myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2004;2(4):371-8.
-
2004: Bensinger William I
The current status of hematopoietic stem cell transplantation for multiple myeloma.
Clinical advances in hematology & oncology : H&O 2004;2(1):46-52.
-
2004: Bensinger William I; Buckner C Dean; Lilleby Kathy; Holmberg Leona; Storb Rainer; Slattery John T
Dose escalation of busulfan with pentoxifylline and ciprofloxacin in patients with breast cancer undergoing autologous transplants.
Oncology 2004;67(5-6):368-75.
-
2003: Maloney David G; Molina Arthur J; Sahebi Firoozeh; Stockerl-Goldstein Keith E; Sandmaier Brenda M; Bensinger William; Storer Barry; Hegenbart Ute; Somlo George; Chauncey Thomas; Bruno Benedetto; Appelbaum Frederick R; Blume Karl G; Forman Stephen J; McSweeney Peter; Storb Rainer
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Blood 2003;102(9):3447-54.
-
2003: Giralt Sergio; Bensinger William; Goodman Mark; Podoloff Donald; Eary Janet; Wendt Richard; Alexanian Raymond; Weber Donna; Maloney David; Holmberg Leona; Rajandran Joseph; Breitz Hazel; Ghalie Richard; Champlin Richard
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.
Blood 2003;102(7):2684-91.
-
2003: Chen Chien-Shing; Boeckh M; Seidel K; Clark J G; Kansu E; Madtes D K; Wagner J L; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W I; Deeg H J; Martin P J; Sanders J E; Storb R; Storek J; Wade J; Siadak M; Flowers M E D; Sullivan K M
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;32(5):515-22.
-
2003: Gutierrez-Delgado F; Holmberg L; Hooper H; Petersdorf S; Press O; Maziarz R; Maloney D; Chauncey T; Appelbaum F; Bensinger W
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen.
Bone marrow transplantation 2003;32(3):279-85.
-
2003: Radich Jerald P; Gooley Ted; Bensinger William; Chauncey Thomas; Clift Reginald; Flowers Mary; Martin Paul; Slattery John; Sultan Debbie; Appelbaum Frederick R
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen.
Blood 2003;102(1):31-5.
-
2003: Rowley S D; Feng Z; Chen L; Holmberg L; Heimfeld S; MacLeod B; Bensinger W I
A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch.
Bone marrow transplantation 2003;31(11):1043-51.
-
2003: Bensinger William I
Recent developments in hematopoietic stem cell transplantation for multiple myeloma.
International journal of hematology 2003;77(3):232-8.
-
2003: Storek Jan; Viganego Federico; Dawson Monja A; Herremans M M P Tineke; Boeckh Michael; Flowers Mary E D; Storer Barry; Bensinger William I; Witherspoon Robert P; Maloney David G
Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.
Blood 2003;101(8):3319-24.
-
2003: Hahn Theresa; Wingard John R; Anderson Kenneth C; Bensinger William I; Berenson James R; Brozeit Greg; Carver Joseph R; Kyle Robert A; McCarthy Philip L
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(1):4-37.
-
2002: Hübel Kai; Carter Rachel A; Liles W Conrad; Dale David C; Price Thomas H; Bowden Raleigh A; Rowley Scott D; Chauncey Thomas R; Bensinger William I; Boeckh Michael
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.
Transfusion 2002;42(11):1414-21.
-
2002: Flowers Mary E D; Parker Pablo M; Johnston Laura J; Matos Alice V B; Storer Barry; Bensinger William I; Storb Rainer; Appelbaum Frederick R; Forman Stephen J; Blume Karl G; Martin Paul J
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Blood 2002;100(2):415-9.
-
2002: Crippa Fulvio; Holmberg Leona; Carter Rachel A; Hooper Heather; Marr Kieren A; Bensinger William; Chauncey Thomas; Corey Lawrence; Boeckh Michael
Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(5):281-9.
-
2001: Weissinger F; Sandmaier B M; Maloney D G; Bensinger W I; Gooley T; Storb R
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.
Blood 2001;98(13):3584-8.
-
2001: Zaucha J M; Gooley T; Bensinger W I; Heimfeld S; Chauncey T R; Zaucha R; Martin P J; Flowers M E; Storek J; Georges G; Storb R; Torok-Storb B
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation.
Blood 2001;98(12):3221-7.
-
2001: Rowley S D; Yu J; Gooley T; Heimfeld S; Holmberg L; Maloney D; Bensinger W I
Trafficking of CD34+ cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis.
Bone marrow transplantation 2001;28(7):649-56.
-
2001: Gutierrez-Delgado F; Maloney D G; Press O W; Golden J; Holmberg L A; Maziarz R T; Hooper H; Buckner C D; Appelbaum F R; Bensinger W I
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.
Bone marrow transplantation 2001;28(5):455-61.
-
2001: Bensinger W I; Maloney D; Storb R
Allogeneic hematopoietic cell transplantation for multiple myeloma.
Seminars in hematology 2001;38(3):243-9.
-
2001: Bensinger W I; Storb R
Allogeneic peripheral blood stem cell transplantation.
Reviews in clinical and experimental hematology 2001;5(2):67-86.
-
2001: McSweeney P A; Niederwieser D; Shizuru J A; Sandmaier B M; Molina A J; Maloney D G; Chauncey T R; Gooley T A; Hegenbart U; Nash R A; Radich J; Wagner J L; Minor S; Appelbaum F R; Bensinger W I; Bryant E; Flowers M E; Georges G E; Grumet F C; Kiem H P; Torok-Storb B; Yu C; Blume K G; Storb R F
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
-
2001: Storek J; Dawson M A; Storer B; Stevens-Ayers T; Maloney D G; Marr K A; Witherspoon R P; Bensinger W; Flowers M E; Martin P; Storb R; Appelbaum F R; Boeckh M
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Blood 2001;97(11):3380-9.
-
2001: Rowley S D; Donaldson G; Lilleby K; Bensinger W I; Appelbaum F R
Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation.
Blood 2001;97(9):2541-8.
-
2001: Gutierrez-Delgado F; Bensinger W
Safety of granulocyte colony-stimulating factor in normal donors.
Current opinion in hematology 2001;8(3):155-60.
-
2001: Gopal A K; Gooley T A; Golden J B; Maloney D G; Bensinger W I; Petersdorf S H; Appelbaum F R; Press O W
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.
Bone marrow transplantation 2001;27(6):593-9.
-
2001: Bensinger W I; Martin P J; Storer B; Clift R; Forman S J; Negrin R; Kashyap A; Flowers M E; Lilleby K; Chauncey T R; Storb R; Appelbaum F R
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
The New England journal of medicine 2001;344(3):175-81.
-
2000: Stiff P; Gingrich R; Luger S; Wyres M R; Brown R A; LeMaistre C F; Perry J; Schenkein D P; List A; Mason J R; Bensinger W; Wheeler C; Freter C; Parker WRL; Emmanouilides C
A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma.
Bone marrow transplantation 2000;26(5):471-81.
-
2000: Chauncey T R; Gooley T A; Lloid M E; Schubert M M; Lilleby K; Holmberg L; Bensinger W I
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
American journal of clinical oncology 2000;23(4):406-11.
-
2000: Gutierrez-Delgado F; Holmberg L A; Hooper H; Appelbaum F R; Livingston R B; Maziarz R T; Weiden P; Rivkin S; Montgomery P; Kawahara K; Bensinger W
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.
Bone marrow transplantation 2000;26(1):51-9.
-
2000: Holmberg L A; Oparin D V; Gooley T; Lilleby K; Bensinger W; Reddish M A; MacLean G D; Longenecker B M; Sandmaier B M
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine.
Bone marrow transplantation 2000;25(12):1233-41.
-
2000: Yu J; Leisenring W; Fritschle W; Heimfeld S; Shulman H; Bensinger W I; Holmberg L A; Rowley S D
Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection.
Bone marrow transplantation 2000;25(11):1157-64.
-
2000: Hawkins D; Barnett T; Bensinger W; Gooley T; Sanders J
Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors.
Medical and pediatric oncology 2000;34(5):328-37.
-
2000: Cavallaro A M; Lilleby K; Majolino I; Storb R; Appelbaum F R; Rowley S D; Bensinger W I
Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Bone marrow transplantation 2000;25(1):85-9.
-
1999: Holmberg L A; Boeckh M; Hooper H; Leisenring W; Rowley S; Heimfeld S; Press O; Maloney D G; McSweeney P; Corey L; Maziarz R T; Appelbaum F R; Bensinger W
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.
Blood 1999;94(12):4029-35.
-
1999: Rowley S D; Prather K; Bui K T; Appel M; Felt T; Bensinger W I
Collection of peripheral blood progenitor cells with an automated leukapheresis system.
Transfusion 1999;39(11-12):1200-6.
-
1999: Yu J; Leisenring W; Bensinger W I; Holmberg L A; Rowley S D
The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield.
Transfusion 1999;39(5):442-50.
-
1998: Holmberg L A; Demirer T; Rowley S; Buckner C D; Goodman G; Maziarz R; Klarnet J; Zuckerman N; Harrer G; McCloskey R; Gersh R; Goldberg R; Nichols W; Jacobs A; Weiden P; Montgomery P; Rivkin S; Appelbaum F R; Bensinger W I
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
Bone marrow transplantation 1998;22(7):651-9.
-
1998: Rowley S D; Loken M; Radich J; Kunkle L A; Mills B J; Gooley T; Holmberg L; McSweeney P; Beach K; MacLeod B; Appelbaum F; Bensinger W I
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
Bone marrow transplantation 1998;21(12):1253-62.
-
1998: Tzung S P; Hackman R C; Hockenbery D M; Bensinger W; Schiffman K; McDonald G B
Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):43-8.
-
1998: Williams O; Demirer T; Lilleby K; Buckner C D; Bensinger W I
Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization.
Journal of clinical apheresis 1998;13(1):1-6.
-
1997: Storek J; Gooley T; Siadak M; Bensinger W I; Maloney D G; Chauncey T R; Flowers M; Sullivan K M; Witherspoon R P; Rowley S D; Hansen J A; Storb R; Appelbaum F R
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.
Blood 1997;90(12):4705-9.
-
1997: Schiffman K; Buckner C D; Maziarz R; Maloney D G; Appelbaum F R; Press O; Gooley T; Holmberg L; Lilleby K; Clift R; Zuckerman N; Klarnet J; Weaver C; Chauncey T; Bensinger W I
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):261-6.
-
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K M; Witherspoon R; Pettinger M; Bensinger W; Buckner C D; Clift R; Flowers M E; Hansen J A; Pepe M; Chauncey T; Sanders J; Thomas E D
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
-
1997: Bensinger W I; Schiffman K S; Holmberg L; Appelbaum F R; Maziarz R; Montgomery P; Ellis E; Rivkin S; Weiden P; Lilleby K; Rowley S; Petersdorf S; Klarnet J P; Nichols W; Hertler A; McCroskey R; Weaver C H; Buckner C D
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.
Bone marrow transplantation 1997;19(12):1183-9.
-
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W I; Chauncey T; Clift R A; Deeg H J; Doney K C; Flowers M E; Hansen J A; Martin P J; Sanders J E; Sullivan K M; Witherspoon R P
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.
Blood 1997;89(10):3890-1.
-
1997: Anderson J E; Gooley T A; Schoch G; Anasetti C; Bensinger W I; Clift R A; Hansen J A; Sanders J E; Storb R; Appelbaum F R
Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.
Blood 1997;89(7):2578-85.
-
1997: Slattery J T; Clift R A; Buckner C D; Radich J; Storer B; Bensinger W I; Soll E; Anasetti C; Bowden R; Bryant E; Chauncey T; Deeg H J; Doney K C; Flowers M; Gooley T; Hansen J A; Martin P J; McDonald G B; Nash R; Petersdorf E W; Sanders J E; Schoch G; Stewart P; Storb R; Sullivan K M; Thomas E D; Witherspoon R P; Appelbaum F R
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
-
1997: Robinson N; Benyunes M C; Thompson J A; York A; Petersdorf S; Press O; Lindgren C; Chauncey T; Buckner C D; Bensinger W I; Appelbaum F R; Fefer A
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study.
Bone marrow transplantation 1997;19(5):435-42.
-
1997: Demirer T; Buckner C D; Storer B; Lilleby K; Rowley S; Clift R; Appelbaum F R; Storb R; Bensinger W I
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):684-90.
-
1996: Bensinger W I; Buckner C D; Shannon-Dorcy K; Rowley S; Appelbaum F R; Benyunes M; Clift R; Martin P; Demirer T; Storb R; Lee M; Schiller G
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Blood 1996;88(11):4132-8.
-
1996: Bensinger W I; Clift R; Martin P; Appelbaum F R; Demirer T; Gooley T; Lilleby K; Rowley S; Sanders J; Storb R; Buckner C D
Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.
Blood 1996;88(7):2794-800.
-
1996: Bensinger W I; Buckner C D; Anasetti C; Clift R; Storb R; Barnett T; Chauncey T; Shulman H; Appelbaum F R
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome.
Blood 1996;88(7):2787-93.
-
1996: Bensinger W I; Demirer T; Buckner C D; Appelbaum F R; Storb R; Lilleby K; Weiden P; Bluming A Z; Fefer A
Syngeneic marrow transplantation in patients with multiple myeloma.
Bone marrow transplantation 1996;18(3):527-31.
-
1996: Brunvand M W; Bensinger W I; Soll E; Weaver C H; Rowley S D; Appelbaum F R; Lilleby K; Clift R A; Gooley T A; Press O W; Fefer A; Storb R; Sanders J E; Martin P L; Chauncey T; Maziarz R T; Zuckerman N; Montgomery P; Dorn R; Weiden P L; Demirer T; Holmberg L A; Schiffman K; McSweeney P A; Buckner C D
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1996;18(1):131-41.
-
1996: Demirer T; Petersen F B; Bensinger W I; Appelbaum F R; Fefer A; Rowley S; Sanders J; Chauncey T; Storb R; Lilleby K; Buckner C D
Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
Bone marrow transplantation 1996;18(1):29-34.
-
1996: McSweeney P A; Wells D A; Shults K E; Nash R A; Bensinger W I; Buckner C D; Loken M R
Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
Blood 1996;88(2):622-32.
-
1996: Schiffman K S; Bensinger W I; Appelbaum F R; Rowley S; Lilleby K; Clift R A; Weaver C H; Demirer T; Sanders J E; Petersdorf S; Gooley T; Weiden P; Zuckerman N; Montgomery P; Maziarz R; Klarnet J P; Rivkin S; Trueblood K; Storb R; Holmberg L; Buckner C D
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
Bone marrow transplantation 1996;17(6):943-50.
-
1996: Demirer T; Buckner C D; Gooley T; Appelbaum F R; Rowley S; Chauncey T; Lilleby K; Storb R; Bensinger W I
Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
Bone marrow transplantation 1996;17(6):937-41.
-
1996: Demirer T; Buckner C D; Appelbaum F R; Clift R; Storb R; Myerson D; Lilleby K; Rowley S; Bensinger W I
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
Bone marrow transplantation 1996;17(5):769-74.
-
1996: Attarian H; Bensinger W I; Buckner C D; McDonald D L; Rowley S D
Microbial contamination of peripheral blood stem cell collections.
Bone marrow transplantation 1996;17(5):699-702.
-
1996: Slattery J T; Kalhorn T F; McDonald G B; Lambert K; Buckner C D; Bensinger W I; Anasetti C; Appelbaum F R
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1484-94.
-
1996: Bensinger W I; Rowley S D; Demirer T; Lilleby K; Schiffman K; Clift R A; Appelbaum F R; Fefer A; Barnett T; Storb R; Chauncey T; Maziarz R T; Klarnet J; McSweeney P; Holmberg L; Maloney D G; Weaver C H; Buckner C D
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
-
1996: Demirer T; Buckner C D; Appelbaum F R; Bensinger W I; Sanders J; Lambert K; Clift R; Fefer A; Storb R; Slattery J T
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(4):491-5.
-
1996: Bensinger W I; Buckner C D; Demirer T; Storb R; Appelbaum F A
Transplantation of allogeneic peripheral blood stem cells.
Bone marrow transplantation 1996;17 Suppl 2():S56-7.
-
1996: Bensinger W I; Buckner C D; Rowley S; Demirer T; Storb R; Appelbaum F A
Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy.
Bone marrow transplantation 1996;17 Suppl 2():S38-9.
-
1996: Bensinger W I; Buckner C D; Rowley S; Storb R; Appelbaum F R
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
Bone marrow transplantation 1996;17 Suppl 2():S19-21.
-
1996: Demirer T; Buckner C D; Appelbaum F R; Lambert K; Bensinger W I; Clift R; Storb R; Slattery J T
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(3):341-6.
-
1996: Demirer T; Buckner C D; Bensinger W I
Optimization of peripheral blood stem cell mobilization.
Stem cells (Dayton, Ohio) 1996;14(1):106-16.
-
1996: Bensinger W I; Clift R A; Anasetti C; Appelbaum F A; Demirer T; Rowley S; Sandmaier B M; Torok-Storb B; Storb R; Buckner C D
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor.
Stem cells (Dayton, Ohio) 1996;14(1):90-105.
-
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T; Clift R A
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):220-6.
-
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T R; Clift R A; Doney K; Flowers M; Hansen J A; Martin P J; Matthews D C; Sanders J E; Shulman H; Sullivan K M; Witherspoon R P; Storb R
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
-
1995: Bensinger W I; Appelbaum F A; Demirer T; Torok-Storb B; Storb R; Buckner C D
Transplantation of allogeneic peripheral blood stem cells.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():63-70.
-
1995: Bensinger W; Appelbaum F; Rowley S; Storb R; Sanders J; Lilleby K; Gooley T; Demirer T; Schiffman K; Weaver C
Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2547-55.
-
1995: Demirer T; Petersen F B; Appelbaum F R; Barnett T A; Sanders J; Deeg H J; Storb R; Doney K; Bensinger W I; Shannon-Dorcy K
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
International journal of radiation oncology, biology, physics 1995;32(4):1103-9.
-
1995: Slattery J T; Sanders J E; Buckner C D; Schaffer R L; Lambert K W; Langer F P; Anasetti C; Bensinger W I; Fisher L D; Appelbaum F R
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.
Bone marrow transplantation 1995;16(1):31-42.
-
1995: Demirer T; Rowley S; Buckner C D; Appelbaum F R; Lilleby K; Storb R; Schiffman K; Bensinger W I
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1714-9.
-
1995: Demirer T; Gooley T; Buckner C D; Petersen F B; Lilleby K; Rowley S; Sanders J; Storb R; Appelbaum F R; Bensinger W I
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
Bone marrow transplantation 1995;15(6):907-13.
-
1995: Demirer T; Bensinger W I
Optimization of peripheral blood stem cell collection.
Current opinion in hematology 1995;2(3):219-26.
-
1995: Demirer T; Weaver C H; Buckner C D; Petersen F B; Bensinger W I; Sanders J; Clift R A; Lilleby K; Anasetti C; Martin P
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):596-602.
-
1995: Bensinger W I; Weaver C H; Appelbaum F R; Rowley S; Demirer T; Sanders J; Storb R; Buckner C D
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.
Blood 1995;85(6):1655-8.
-
1995: Langenmayer I; Weaver C; Buckner C D; Lilleby K; Appelbaum F R; Longin K; Rowley S; Storb R; Singer J; Bensinger W I
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
Bone marrow transplantation 1995;15(2):241-6.
-
1995: Lynch M H; Petersen F B; Appelbaum F R; Bensinger W I; Clift R A; Storb R; Sanders J E; Hansen J A; Buckner C D
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.
Bone marrow transplantation 1995;15(1):59-64.
-
1995: Bensinger W
Peripheral blood stem cell transplantation.
Cancer treatment and research 1995;76():169-93.
-
1994: Weaver C H; Petersen F B; Appelbaum F R; Bensinger W I; Press O; Martin P; Sandmaier B; Deeg H J; Hansen J A; Brunvand M
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2559-66.
-
1994: Weaver C H; Clift R A; Deeg H J; Storb R; Appelbaum F R; Bensinger W; Doney K; Hansen J A; Martin P O; Sanders J
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
Bone marrow transplantation 1994;14(6):885-93.
-
1994: Schuening F; Miller A D; Torok-Storb B; Bensinger W; Storb R; Reynolds T; Fisher L; Buckner C D; Appelbaum F R
Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantation.
Human gene therapy 1994;5(12):1523-34.
-
1994: Clift R A; Buckner C D; Thomas E D; Bryant E; Anasetti C; Bensinger W I; Bowden R; Deeg H J; Doney K C; Fisher L D
Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.
Blood 1994;84(12):4368-73.
-
1994: Weaver C H; Bensinger W I; Appelbaum F R; Lilleby K; Sandmaier B; Brunvand M; Rowley S; Petersdorf S; Rivkin S; Gooley T
Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
Bone marrow transplantation 1994;14(5):813-9.
-
1994: Clift R A; Buckner C D; Thomas E D; Bensinger W I; Bowden R; Bryant E; Deeg H J; Doney K C; Fisher L D; Hansen J A
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.
Blood 1994;84(6):2036-43.
-
1994: Storb R; Etzioni R; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W; Bryant E; Clift R; Deeg H J; Doney K
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Blood 1994;84(3):941-9.
-
1994: Bensinger W I; Longin K; Appelbaum F; Rowley S; Weaver C; Lilleby K; Gooley T; Lynch M; Higano T; Klarnet J
Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation.
British journal of haematology 1994;87(4):825-31.
-
1994: Demirer T; Buckner C D; Lilleby K; Weaver C; Longin K; Appelbaum F R; Bensinger W I
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease.
Cancer 1994;74(2):715-21.
-
1994: Storb R; Leisenring W; Deeg H J; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Doney K; Hansen J
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
Blood 1994;83(9):2749-50.
-
1994: Rowley S D; Bensinger W I; Gooley T A; Buckner C D
Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation.
Blood 1994;83(9):2731-6.
-
1994: Weaver C H; Longin K; Buckner C D; Bensinger W
Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor.
Bone marrow transplantation 1994;13(4):411-5.
-
1994: Neubauer M A; Benyunes M C; Thompson J A; Bensinger W I; Lindgren C G; Buckner C D; Fefer A
Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 1994;13(3):311-6.
-
1993: Clift R A; Bianco J A; Appelbaum F R; Buckner C D; Singer J W; Bakke L; Bensinger W I; Bowden R A; McDonald G B; Schubert M
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Blood 1993;82(7):2025-30.
-
1993: Doney K; Buckner C D; Fisher L; Petersen F B; Sanders J; Appelbaum F R; Anasetti C; Badger C; Bensinger W; Deeg H J
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(4):315-21.
-
1993: Weaver C H; Buckner C D; Longin K; Appelbaum F R; Rowley S; Lilleby K; Miser J; Storb R; Hansen J A; Bensinger W
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor.
Blood 1993;82(7):1981-4.
-
1993: Anderson J E; Appelbaum F R; Fisher L D; Schoch G; Shulman H; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Doney K
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.
Blood 1993;82(2):677-81.
-
1993: Petersen F B; Lynch M H; Clift R A; Appelbaum F R; Sanders J E; Bensinger W I; Benyunes M C; Doney K; Fefer A; Martin P
Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1353-60.
-
1993: Weaver C H; Appelbaum F R; Petersen F B; Clift R; Singer J; Press O; Bensinger W; Bianco J; Martin P; Anasetti C
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1329-35.
-
1993: Bensinger W; Singer J; Appelbaum F; Lilleby K; Longin K; Rowley S; Clarke E; Clift R; Hansen J; Shields T
Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor.
Blood 1993;81(11):3158-63.
-
1993: Bensinger W I; Price T H; Dale D C; Appelbaum F R; Clift R; Lilleby K; Williams B; Storb R; Thomas E D; Buckner C D
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.
Blood 1993;81(7):1883-8.
-
1993: Schiffman K; Clift R; Appelbaum F R; Sanders J; Bensinger W; Petersen F B; Rowley S; Hill R; Martin P; Storb R
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.
Bone marrow transplantation 1993;11(3):227-32.
-
1993: Radich J P; Sanders J E; Buckner C D; Martin P J; Petersen F B; Bensinger W; McDonald G B; Mori M; Schoch G; Hansen J A
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):304-13.
-
1992: Andrews R G; Bensinger W I; Knitter G H; Bartelmez S H; Longin K; Bernstein I D; Appelbaum F R; Zsebo K M
The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons.
Blood 1992;80(11):2715-20.
-
1992: Clift R A; Buckner C D; Appelbaum F R; Schoch G; Petersen F B; Bensinger W I; Sanders J; Sullivan K M; Storb R; Singer J
Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1723-9.
-
1992: Andrews R G; Bryant E M; Bartelmez S H; Muirhead D Y; Knitter G H; Bensinger W; Strong D M; Bernstein I D
CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons.
Blood 1992;80(7):1693-701.
-
1992: Bensinger W I; Buckner C D; Clift R A; Petersen F B; Bianco J A; Singer J W; Appelbaum F R; Dalton W; Beatty P; Fefer A
Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1492-7.
-
1992: Bensinger W I
Supportive care in marrow transplantation.
Current opinion in oncology 1992;4(4):614-23.
-
1992: Storb R; Pepe M; Deeg H J; Anasetti C; Appelbaum F R; Bensinger W; Buckner C D; Cliff R A; Doney K; Hansen J
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Blood 1992;80(2):560-1.
-
1992: Petersen F B; Buckner C D; Appelbaum F R; Sanders J E; Bensinger W I; Storb R; Deeg H J; Witherspoon R P; Sullivan K M; Clift R A
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1992;10(1):83-8.
-
1992: Petersen F B; Deeg H J; Buckner C D; Appelbaum F R; Storb R; Clift R A; Sanders J E; Bensinger W I; Witherspoon R P; Sullivan K M
Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.
International journal of radiation oncology, biology, physics 1992;23(5):1027-32.
-
1992: Storb R; Longton G; Anasetti C; Appelbaum F R; Beatty P; Bensinger W; Crawford S; Deeg H J; Doney K; Fefer A
Changing trends in marrow transplantation for aplastic anemia.
Bone marrow transplantation 1992;10 Suppl 1():45-52.
-
1992: Sullivan K M; Mori M; Sanders J; Siadak M; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W; Bowden R; Buckner C D
Late complications of allogeneic and autologous marrow transplantation.
Bone marrow transplantation 1992;10 Suppl 1():127-34.
-
1992: Berenson R J; Bensinger W I; Kalamasz D F; Heimfeld S; Goffe R A; Berninger R W; Peterson D R; Thompson P; Strong D M
Transplantation of stem cells enriched by immunoadsorption.
Progress in clinical and biological research 1992;377():449-57; discussion 458-9.
-
1991: Storb R; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Deeg H J; Doney K; Hansen J; Loughran T
Marrow transplantation for severe aplastic anemia and thalassemia major.
Seminars in hematology 1991;28(3):235-9.
-
1991: Bensinger W I; Hadlock J; Slichter S J
Identification of alloimmunized patients: use of radiolabeled allogeneic platelet kinetic measurements and platelet antibody tests.
Blood 1991;77(11):2372-8.
-
1991: Doney K; Fisher L D; Appelbaum F R; Buckner C D; Storb R; Singer J; Fefer A; Anasetti C; Beatty P; Bensinger W
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Bone marrow transplantation 1991;7(6):453-9.
-
1991: Clift R A; Buckner C D; Appelbaum F R; Bryant E; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.
Blood 1991;77(8):1660-5.
-
1991: Berenson R J; Bensinger W I; Hill R S; Andrews R G; Garcia-Lopez J; Kalamasz D F; Still B J; Spitzer G; Buckner C D; Bernstein I D
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma.
Blood 1991;77(8):1717-22.
-
1990: Clift R A; Buckner C D; Appelbaum F R; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I; Doney K
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
Blood 1990;76(9):1867-71.
-
1990: Petersen F B; Appelbaum F R; Hill R; Fisher L D; Bigelow C L; Sanders J E; Sullivan K M; Bensinger W I; Witherspoon R P; Storb R
Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):638-47.
-
1990: Bensinger W I; Berenson R J; Andrews R G; Kalamasz D F; Hill R S; Bernstein I D; Lopez J G; Buckner C D; Thomas E D
Positive selection of hematopoietic progenitors from marrow and peripheral blood for transplantation.
Journal of clinical apheresis 1990;5(2):74-6.
-
1990: Bensinger W I; Berenson R J
Peripheral blood and positive selection of marrow as a source of stem cells for transplantation.
Progress in clinical and biological research 1990;337():93-8.
-
1990: Berenson R J; Bensinger W I; Hill R; Andrews R G; Garcia-Lopez J; Kalamasz D F; Still B J; Buckner C D; Bernstein I D; Thomas E D
Stem cell selection--clinical experience.
Progress in clinical and biological research 1990;333():403-10; discussion 411-3.
-
1989: Petersen F B; Buckner C D; Appelbaum F R; Clift R A; Sanders J E; Bensinger W I; Storb R; Witherspoon R P; Sullivan K M; Bearman S I
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1989;4(6):617-23.
-
1989: Storb R; Deeg H J; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Hansen J
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
British journal of haematology 1989;72(4):567-72.
-
1989: Bensinger W; Petersen F B; Banaji M; Buckner C D; Clift R; Slichter S J; Storb R; Thomas E D
Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.
Bone marrow transplantation 1989;4(4):409-14.
-
1989: Storb R; Deeg H J; Pepe M; Appelbaum F; Anasetti C; Beatty P; Bensinger W; Berenson R; Buckner C D; Clift R
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.
Blood 1989;73(6):1729-34.
-
1989: Hill R S; Mazza P; Amos D; Buckner C D; Appelbaum F R; Martin P; Still B J; Sica S; Berenson R; Bensinger W
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.
Bone marrow transplantation 1989;4(1):69-74.
-
1989: Anasetti C; Amos D; Beatty P G; Appelbaum F R; Bensinger W; Buckner C D; Clift R; Doney K; Martin P J; Mickelson E
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
The New England journal of medicine 1989;320(4):197-204.
-
1988: Petersen F B; Sanders J E; Storb R; Bensinger W I; Clift R A; Buckner C D
Inadvertent administration of a greater-than-usual pre-marrow transplant dose of busulfan--report of a case.
Transplantation 1988;45(4):821-2.
-
1988: Berenson R J; Andrews R G; Bensinger W I; Kalamasz D; Knitter G; Buckner C D; Bernstein I D
Antigen CD34+ marrow cells engraft lethally irradiated baboons.
The Journal of clinical investigation 1988;81(3):951-5.
-
1988: Storb R; Deeg H J; Fisher L; Appelbaum F; Buckner C D; Bensinger W; Clift R; Doney K; Irle C; McGuffin R
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Blood 1988;71(2):293-8.
-
1988: Sanders J E; Buckner C D; Clift R A; Fefer A; McGuffin R; Storb R; Appelbaum F; Bensinger W; Beatty P; Doney K
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation.
Bone marrow transplantation 1988;3(1):11-9.
-
1987: Bensinger W I; Buckner C D; Clift R A; Williams B M; Banaji M; Thomas E D
Comparison of techniques for dealing with major ABO-incompatible marrow transplants.
Transplantation proceedings 1987;19(6):4605-8.
-
1987: Sanders J; Buckner C D; Bensinger W I; Levy W; Chard R; Thomas E D
Experience with marrow harvesting from donors less than two years of age.
Bone marrow transplantation 1987;2(1):45-50.
-
1987: Berenson R J; Bensinger W I; Kalamasz D; Schuening F; Deeg H J; Graham T; Storb R
Engraftment of dogs with Ia-positive marrow cells isolated by avidin-biotin immunoadsorption.
Blood 1987;69(5):1363-7.
-
1987: Storb R; Deeg H J; Whitehead J; Farewell V; Appelbaum F R; Beatty P; Bensinger W; Buckner C D; Clift R A; Doney K
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
Transplantation proceedings 1987;19(1 Pt 3):2608-13.
-
1987: Jin N R; Hill R; Segal G; Still B; Petersen F B; Amos D; Buckner C D; Clift R; Bensinger W; Martin P
Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor.
Experimental hematology 1987;15(1):93-8.
-
1987: Williams B M; Sanders J E; Clift R A; Hickman R O; Bensinger W I; Buckner C D; Thomas E D
Use of arteriovenous shunts and right atrial catheters for daily granulocyte collection.
Journal of clinical apheresis 1987;3(3):171-3.
-
1986: Storb R; Deeg H J; Farewell V; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Hansen J
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease.
Blood 1986;68(1):119-25.
-
1986: Berenson R J; Bensinger W I; Kalamasz D
Positive selection of viable cell populations using avidin-biotin immunoadsorption.
Journal of immunological methods 1986;91(1):11-9.
-
1986: Storb R; Deeg H J; Whitehead J; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Doney K; Farewell V
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
The New England journal of medicine 1986;314(12):729-35.
-
1986: Berenson R J; Bensinger W I; Kalamasz D; Martin P
Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption.
Blood 1986;67(2):509-15.
-
1985: Deeg H J; Storb R; Thomas E D; Flournoy N; Kennedy M S; Banaji M; Appelbaum F R; Bensinger W I; Buckner C D; Clift R A
Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia.
Blood 1985;65(6):1325-34.
-
1985: Stewart P; Buckner C D; Bensinger W; Appelbaum F; Fefer A; Clift R; Storb R; Sanders J; Meyers J; Hill R
Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission.
Experimental hematology 1985;13(4):267-72.
-
1985: Irle C; Deeg H J; Buckner C D; Kennedy M; Clift R; Storb R; Appelbaum F R; Beatty P; Bensinger W; Doney K
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.
Leukemia research 1985;9(10):1255-61.
-
1984: Williams B M; Clift R A; Buckner C D; Hickman R O; Sanders J E; Stewart P S; Bensinger W I; Banaji M; Thomas E D
Granulocyte collection by continuous-flow centrifugation using arteriovenous shunts.
Journal of clinical apheresis 1984;2(2):206-9.
Sign-in to see more
